The Diagnosis and Management of Cardiac Failure

Sutton GC . Epidemiologic aspects of heart failure. Am Heart J 1990; 120: 1538–1540.

Wheeldon NM , MacDonald TM , Flucker CJ , McKendrick AD , McDevitt DG , Struthers AD . Echocardiography in chronic heart failure in the community. Q J Med 1993; 86: 17–23.

Davies MK . Modern management of heart failure. Br J Hospital Med. 1992; 47: 1624.

Clarke KW , Gray D , Hampton JR . Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584–587.

Shocken DD , Arrieta MI , Leaverton PE . Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 29: 301–306.

McMurray J , McDonagh T , Morrison CE , Dargie HJ . Trends in hospitalisation for heart failure in Scotland 1980–1990. Eur Heart J 1993; 14: 1158–1162.

McMurray J , Hart W , Rhodes G . An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 1993: 6: 99–110.

McKee PA , Castelli WP , McNamara PM , Kannel WB . The natural history of congestive heart failure. N Engl J Med 1971; 285: 781–787.

Remes J , Miettinen H , Reunanen A , Pyorala K . Validity of clinical diagnosis in primary health care. Eur Heart J 1991; 12: 315–321.

Editorial. Clinical signs in heart failure. Lancet 1989; ii: 309–310.

Gillespie ND , Struthers AD , Pringle SD . The assessment of left ventricular function by echocardiography. Scot Med J 1995; 40: 132–133.

The Trandolapril Cardiac Evaluation study: Rationale, design and baseline characteristics of the screened population. Am J Cardiol 1994; 73: 44C–50C.

Francis CM , Caruana L , Kearney P . Open access echocardiography in the management of heart failure in the community. BMJ 1995; 310: 634–636.

Parameshwar J , Poole-Wilson PA , Sutton GC . Heart failure in a district general hospital. J R Coll Physicians London 1992; 26: 139–142.

Hillis G , Trent R , Winton P , MacLeod A , Jennings K . Angiotensinconverting enzyme inhibitors: Are we ignoring the evidence? Q J Med 1996; 89: 145–150.

Struthers AD . Prospects for using ablood sample in the diagnosis of heart failure. Q J Med 1995; 88: 303–306.

Coats AJS . Exercise rehabilitation in chronic heart failure. J Am Coll Cardiol 1993; 22 (suppl 4): 172A–177A.

de Bono DP . Shedding the load — vasodilators in treating chronic heart failure. Q J Med 1993; 86: 1–2.

The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435.

The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302.

Cohn JN , Archibald DG , Ziesche S . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310.

McMurray J , Francis M . Problems solved and lives saved? Chronic heart failure. Br J Clin Pharmacol 1994; 48: 29–36.

Pitt B . Angiotensin-converting inhibitors in patients with congestive heart failure: A class effect? Am J Cardiol 1991; 68: 106–108.

Reid JL , MacFadyen RJ , Squire IB , Lees KR . Angiotensin-Converting inhibitors in heart failure: Blood pressure changes after first dose. Am Heart J 1992; 126: 794–797.

Testa MA , Anderson RB , Nackley JF , Hollenberg NK . Quality of life and antihypertensive therapy in men. A comparison of Captopril with enalapril. N Engl J Med 1993; 328: 907–913.

Cleland JGF , Hubbard WN , Pittard J , Poole-Wilson PA , Sutton GC . ACE inhibitors in heart failure. What dose? Postgrad Med J 1995; 71: 65–66.

Clark AL , Coats AJS . Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. BMJ 1995; 310: 973–974.

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685–691.

Cleland JGF , Dutka DP . Optimising heart failure pharmacotherapy: The ideal combination. Br Heart J 1994; 72 (suppl): S73–S79.

Packer M , Gheorghiade M , Young JB . Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329: 1–7.

Yusuf S , Peto R , Lewis J . Beta blockade during and after myocardial infarction: An overview of the randomised trials. Prog Cardiovasc Dis 1985; 27: 335–371.

CIBIS investigators and committees. A randomised trial of ß blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study. Circulation 1994; 90; 1765–1773.

Cohn JN , Archibald DG , Ziesche S . Effect of vasodilator therapy on mortality in chronic congestive cardiac heart failure; results of a Veterans Administration Co-operative Study. N Engl J Med 1986; 314: 1547–1552.

Olsen SL , Gilbert EM , Renlund DG , Taylor DO , Yanowitz FD , Bristow MR . Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double blind randomized study. J Am Coll Cardiol 1995; 25; 1225–1231.

Australia-New Zealand Heart Failure Research Collaberative Group. Effects of Carvedilol, a vasodilator β-blocker, in patients with congestive heart failure due to ischaemic heart disease. Circulation 1995; 92: 212–218.

Henderson AH . Amiodarone for chronic heart failure. Lancet 1994; 344: 489–490.

Breihardt G . Amiodarone in patients with heart failure. N Engl J Med 1995; 333: 121–122.

Doval HC , Nul DR , Grancelli HO . Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493–498.

Singh SN , Fletcher RD , Fisher SG . Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77–82.

Nicklas JM , McKenna WJ , Stewart RA . Prospective, double blind, placebo controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991; 122: 1016–1021.

Baker DW , Wright RF . Management of heart failure. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 1994; 272: 1614–1618.

Brundage BH , Massie BM , Botvinick EH . Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984; 3: 902–908.

Hayward MP , Cumming DVE . Myoplasty-a surgical option for end-stage heart failure. Br J Hosp Med 1995; 53: 435–438.

Swanton RH . End-stage cardiac failure: Surgical options. Br J Hosp Med 1995; 53: 428–429.

Taylor AJ , Bergin JD . Cardiac transplantation for the cardiologist not trained in transplantation. Am Heart J 1995; 129: 578–592.

Milano CA , Allen LF , Rockman HA . Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science 1994; 264; 582–586.

Williams SR . Boosting cardiac contractility with genes. N Engl J Med 1995; 332: 817–818.